PT - JOURNAL ARTICLE AU - Andrei Lobiuc AU - Mihai Dimian AU - Roxana Gheorghita AU - Olga Sturdza AU - Mihai Covasa TI - Analysis of genome characteristics and transmission of SARS-CoV-2 strains in North-East of Romania during the first COVID-19 outbreak AID - 10.1101/2020.12.22.20248741 DP - 2020 Jan 01 TA - medRxiv PG - 2020.12.22.20248741 4099 - http://medrxiv.org/content/early/2020/12/24/2020.12.22.20248741.short 4100 - http://medrxiv.org/content/early/2020/12/24/2020.12.22.20248741.full AB - Romania officially declared its first SARS-CoV-2 case on February 26, 2020. The first and largest COVID-19 outbreak in Romania was recorded in Suceava, N/E region of the country, and originated at the Suceava regional county hospital. Following sheltering-in-place measures, infection rates decreased, only to rise again after relaxation of measures. This study describes the incursion of SARS-CoV-2 in Suceava and other parts of Romania and analyzes the mutations and their association with clinical manifestation of the disease during the period of COVID-19 outbreak. Phylogenetic analysis indicated multiple sites of origin for SARS-CoV-2 strains in Suceava, specifically from Spain, Italy and Russia, but also other strains related to those from Czech Republic, Belgium and France. Most Suceava samples contained mutations common to European lineages, such as A20268G, however aproximately 10% of samples were missing such mutations, indicating a possible different origin. While overall genome regions ORF1ab, S and ORF7 were subject to most mutations, several recurring mutations such as C27707T were identified, and these were mainly present in severe forms of the disease. Non-synonymous mutations, such as C3225A (Thr987Asn in NSP3a domain), associated with changes in a protein responsible for decreasing viral tethering in human host were also present. Patients with diabetes and hypertension exhibited eight and three time,s respectively, higher odds ratios of acquiring severe forms of the disease and these were mainly related to C27707T mutation. These results will aid in tracing virus movement throughout Romania and identification of infectivity, virulence and pathogenicity.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by a grant of The Ministry of Education and Research, UEFISCDI, project number PN-III-P2-2.1-SOL-2020-0142, within PNCDI III.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Patients signed informed consent for data access and the study was approved by the University of Suceava Research Ethics Committee.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData submitted to GISAID https://www.gisaid.org/ For Accesion info, refer to S1 Table https://www.gisaid.org/ AsnAsparagineGISAIDGISAID EpiFlu™ Database and Data, https://www.gisaid.org/IL-8Interleukin 8kbkilobasesMAPmitogen activated protein kinaseNF-êBNuclear factor – kappa BNSP3aNon-structural protein 3, subdomain 3aORFOpen reading frameThrThreonine